Biobase to Market Annovar Annotation Tool | GenomeWeb

NEW YORK (GenomeWeb News) – Biobase today said that it has inked an agreement with the University of Southern California and the Children's Hospital of Philadelphia to exclusively market and distribute their Annovar genomic annotation tool.

The software enables annotation of genomic variants on a variety of specieds including humans, said Beverly, Mass.-based Biobase. It rapidly screens and annotates genetic variants detected with next-generation sequencing platforms on a genome-wide level.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.